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Feline immunodeficiency virus (FIV) is a lentivirus associated with an immunodeficiency syndrome of the domestic cat.
A short open reading frame (ORF2), of unknown function, is present in all FIV isolates. We have investigated the role of
ORF2 in determining the cell tropism of two infectious molecular clones of FIV. FIV-PPR is able to productively infect feline
peripheral blood leukocytes (PBLs) and a T lymphocyte cell line (MCH5-4), but not a feline astrocyte cell line (G355-5) or
Crandell feline kidney cells (CrFK). In contrast, FIV-34TF10 is able to productively infect G355-5 and CrFK cells, but not
PBLs or MCH5-4 cells. The major difference in these FIV clones is that ORF2 in FIV-PPR is capable of encoding a 79-
amino-acid peptide, whereas there is a stop codon in ORF2 after 43 amino acids in FIV-34TF10. We performed site-directed
mutagenesis to change the stop codon (TGA) in FIV-34TF10 to a tryptophan (TGG), the amino acid present at this location
in FIV-PPR. FIV-34TF10 with ORF2 repaired (FIV-ORF2rep) productively infected PBLs, MCH5-4 cells, and primary macro-
phages, as well as CrFK and G355-5 cells, indicating that a protein encoded by ORF2 plays a role in determining the host
cell tropism of FIV. ORF2 contains hydrophobic, acidic, and leucine-rich domains similar to those shown to be important
for transactivating proteins of other lentiviruses. Coexpression of a plasmid expressing the ORF2 gene product with another
construct expressing the chloramphenicol acetyl transferase (CAT) gene driven by the FIV LTR, resulted in transactivation
of CAT expression in both feline and human cells. q 1996 Academic Press, Inc.
INTRODUCTION retroviruses (reviewed in Clements and Payne, 1994),
have not been identified. As with visna virus transactiva-
Feline immunodeficiency virus (FIV) is a lentivirus that tion, no TAR-like structure has been found in FIV (Gdovin
causes an immunodeficiency syndrome in cats similar and Clements, 1992). However, many transactivating pro-
to AIDS caused by HIV in humans (Pedersen et al., 1987). teins can exert their effects through other cellular pro-
The genetic organization of FIV is similar to other mem- teins so that TAR is not necessarily a prerequisite for
bers of the lentivirinae in that it encodes the major struc- virus-directed transactivation. (Gdovin and Clements,
tural genes, gag, pol, and env, as well as certain regula- 1992; Taylor et al., 1994).
tory genes, vif and rev (Talbott et al., 1989; Phillips et al., FIV and visna virus also share some homology in the
1992; Olmsted et al., 1989a; Elder and Phillips, 1994). LTR (Talbott et al., 1989; Hess et al., 1989). The AP-4/
There is also a short open reading frame (ORF), desig- AP-1 sites have been shown to be important in basal
nated ORF2, of previously undescribed function, encoded expression and transactivation in both viruses (Sparger
by a region of the genome between the vif and env genes et al., 1992; Neuveut et al., 1993; Thompson et al., 1994).
(Olmsted et al., 1989b; Phillips et al., 1992; Tomonaga et However, the FIV protein responsible for this transactiva-
al., 1993b). This ORF has some similarity in amino acid tion had not been found, and although ORF2 was a candi-
domains to transactivating proteins of other retroviridae, date, no activity had been shown with constructs con-
in particular to visna virus (Carruth et al., 1994) and cap- taining the isolated ORF2 (Thompson et al., 1994; Sparger
rine arthritis and encephalitis virus transactivators (Kalin- et al., 1992).
ski et al., 1994). Studies on the expression patterns of Transfection studies by Tomonaga et al. (1993a)
FIV mRNAs show that FIV proteins are produced by a showed that an ORF2 mutant virus exhibited a severe
cascade of splicing events of the primary full-length RNA defect in productive replication in PBLs, but retained
transcript (Tomonaga et al., 1993b; Phillips et al., 1992; wild-type growth characteristics in CrFK cells. They also
de Parseval et al., manuscript in preparation). ORF2 is showed that mutant virus from these cells was able to
contained in polycistronic mRNA transcripts encoding vif/ infect PBLs and two T cell lines, but failed to replicate
env, env, vif/rev, and rev alone, but transcripts containing and propagate efficiently.
either ORF2 alone or any additional exon of ORF2, as is The purpose of this study is to investigate the involve-
seen in transactivating proteins of some other complex ment of FIV-ORF2 in determining the growth properties of
two infectious molecular clones of FIV in various cellular
environments. One clone, FIV-PPR is able to infect feline1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (619) 554-6112. peripheral blood leukocytes (PBLs) and a T cell line
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(MCH5-4) but not a feline astrocyte cell line (G355-5) or was then used as a primer for PCR with another primer
from the 5* end of FIV-34TF10. The PCR product in thisCrandell feline kidney cells (CrFK), whereas another
clone, FIV-34TF10, is able to productively infect G355-5 case was from bases 542 to 6490 of FIV-34TF10 and
contained the ORF2 mutations. Wild-type FIV-34TF10and CrFK cells but not PBLs (Phillips et al., 1990). One
significant difference between these two clones is the cloned in pUC119 and the final 6-kb PCR product were
then digested with KpnI and Nsi I and the 3722-bp KpnIpremature termination of ORF2 in FIV-34TF10 (Talbott et
al., 1989; Phillips et al., 1992). ORF2 in FIV-PPR encodes to Nsi I fragment of FIV-34TF10, from bases 2674 to 6396,
was replaced with the corresponding region from thea putative protein of 79 amino acids, whereas there is a
stop codon in ORF2 after 43 amino acids in FIV-34TF10. PCR product. A clone was sequenced to verify the muta-
genesis and to check the Nsi I and KpnI junctions. ThisWe have performed site-directed mutagenesis to change
the stop codon in FIV-34TF10 to a tryptophan, the amino clone, FIV-ORF2rep, was then used to transfect G355-5
cells.acid present at this location in FIV-PPR, and have studied
the in vitro tropism of this ORF2-repaired clone of FIV-
Propagation of FIV-ORF2rep in G355-5 cells34TF10. The results show that an open ORF2 reading
frame in FIV-34TF10 results in productive growth in T
Molecular clones FIV-34TF10, FIV-PPR, and FIV-OR-
lymphocytes and primary macrophages, while improving
F2rep were transfected into G355-5 cells by cationic lipo-
growth kinetics in CrFK and G355-5 cells. CAT assays
some-mediated transfection using the transfection re-
were also performed to determine the transactivating
agent DOTAP (BMB). Briefly, 20 mg DNA and 40 mg DO-
properties of ORF2, either expressed from the virus itself,
TAP in PBS were mixed and left at room temperature for
or from a plasmid containing the ORF2 gene under the
15 min in a final volume of 160 ml. Twelve milliliters of
control of the CMV promotor.
complete McCoys medium was added to the DNA/DO-
TAP mix and 4 ml per flask was then added to each of
MATERIALS AND METHODS three T25 flasks of G355-5 cells. The cells were split the
following day and followed for RT activity. Mock-Cells and virus
transfected controls consisted of PBS mixed with DOTAP.
CrFK cells were obtained from the ATCC (Fischinger
et al., 1973) and a feline astrocyte-derived cell line (G355- Infections
5) was kindly provided by Don Blair (NIH, Bethesda, MD).
Virus supernatants from infected cells, with RT valuesPBMCs were prepared from whole feline blood by Ficoll –
of 500K, were used to infect PBLs, MCH5-4 cells, andPaque gradient purification and cultured overnight in
unstimulated macrophages. Also, supernatants from FIV-RPMI 1640 medium containing 15% FBS, 7.5 mg/ml Con
34TF10 and FIV-ORF2rep were used to infect G355-5 andA (Sigma, St. Louis, MO), 5.51 1002 mM b-mercaptoetha-
CrFK cells to confirm that FIV-ORF2rep also retained thenol, and 100 U/ml human recombinant IL-2 (a gift of Hof-
ability to grow in these cells.mann–LaRoche). Nonadherent cells (T cells) were then
removed and cultured in the same medium. The adherent
LTR and ORF2 constructs
cells (macrophages) were fed with RPMI 1640 containing
15% FBS, but no Con A or IL-2. MCH5-4 cells are an The LTR–CAT constructs have been previously de-
uninfected continuous feline T cell line and were kindly scribed by Thompson et al. (1994). The ORF2 genes from
provided by Chris Grant (Custom Monoclonals, W. Sacra- FIV-PPR and FIV-34TF10 were amplified by PCR and the
mento, CA). FIV strains used in this study were FIV- products cloned into the pCR II vector using the TA clon-
34TF10, a molecular clone derived from the Petaluma ing kit (Invitrogen, La Jolla, CA). Clones containing ORF2
isolate (Talbott et al., 1989), and FIV-PPR, a molecular were then digested with SpeI and NotI for insertion into
clone derived from the San Diego isolate (Phillips et al., the XbaI/NotI site of pRc/CMV (Invitrogen). Clones were
1990). selected and the presence and orientation of ORF2 were
confirmed by sequencing using the Sequenase 2.0 kit
Mutagenesis (USB—United States Biochemicals, Cleveland, OH).
In order to repair the FIV-34TF10 ORF2, the mega- Transfections and CAT assays
primer method of PCR mutagenesis was used, as shown
in Fig. 1 (Sarkar and Sommer, 1990). A mutagenic primer DNA was purified from Escherichia coli either by using
the Qiagen plasmid maxiprep kits (Qiagen, Chatsworth,was synthesized to incorporate an A r G change to
repair the termination codon at position 6122 in FIV- CA) or by the Merlin service offered by Bio101 (Vista, CA).
Constructs were transfected into adherent cells using a34TF10. This primer also generated a PstI site at position
6108 that could be used to confirm the incorporation of calcium phosphate precipitation method (Chen and
Okayama, 1988). Briefly, cells were seeded at 1.5–2 1this mutation without altering the ORF2 reading frame.
This generated a PCR product of 390 bp, corresponding 106/100 mm dish 24 hr prior to transfection. The transfec-
tion mix contained 10 mg effector DNA, 5 mg internalto bases 6100–6490 of the FIV-34TF10 genome, which
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FIG. 1. (A) A mutagenic primer was synthesized to incorporate an A r G change to repair the termination codon at position 6122 in FIV-34TF10.
This primer also generated a PstI site at position 6108 that could be used to confirm the incorporation of this mutation. Mutated nucleotides are
indicated by an ‘‘X.’’ (B) PCR with primers 187 and 72 generated a PCR product of 390 bp corresponding to bases 6100–6490 of the FIV genome.
This megaprimer was then used for PCR with primer 60 from the 5* end of FIV-34TF10. The PCR product in this case was from bases 542 to 6490
of FIV-34TF10 and contained the ORF2 mutations. Wild-type FIV-34TF10, cloned in pUC119, and the final 6 kb PCR product were then digested
KpnI and Nsi I. The 3722-bp KpnI to Nsi I fragment of FIV-34TF10 from bases 2674 to 6396 was replaced with the corresponding region from the
PCR product.
control DNA (pRSV-b-Gal), and 1 or 10 mg LTR–CAT ucts were separated by thin-layer chromatography (In-
vitrogen) and the percentage acetylation was determinedDNA, in CrFK and HeLa cells respectively, in 450 ml dH2O.
CaCl2 was added to 250 mM before mixing with an equal using a phosphorimager (Molecular Dynamics, Sun-
nyvale, CA).volume of 21 BES (50 mM BES (Calbiochem, La Jolla,
CA), 280 mM NaCl, 1.5 mM Na2HPO4 , pH 6.95). While
the DNA was left to precipitate for 20 min at RT, the cells RESULTS
were washed with HBSS and fresh medium was added.
Transfections and infections
The DNA solution was added dropwise to the medium
on the cells while swirling and the cells were incubated In order to determine the role of ORF2 in FIV cell tro-
pism, the prematurely terminated ORF2 gene in FIV-overnight in 5% CO2 . After 24 hr the cells were washed
with ice-cold HBSS, fresh medium was added, and the 34TF10 was repaired such that a protein of 79 amino
acids was produced, as is seen in other strains of FIV.cells were incubated for an additional 24 hr. Cells were
harvested the next day by scraping into 200 ml 0.25 M The FIV-ORF2rep clone of FIV-34TF10 was transfected
into G355-5 cells and the course of infection followed byTris, pH 7.8, and lysed by three freeze–thaw cycles. Cell
debris was removed by centrifugation and the protein RT assay. By 3 weeks posttransfection the RT value from
the FIV-ORF2rep supernatant was500,000 cpm/ml andcontent of the supernatant and transfection efficiency
were determined by a standard b-galactosidase (b-Gal) equal to that from the wild-type FIV-34TF10 supernatant
(Fig. 2). Cells transfected with FIV-PPR DNA or mock-assay (Hall et al., 1983). Extracts were normalized for
protein content and 4 units of each was assayed for CAT transfected cells showed no sign of infection. Superna-
tants FIV-ORF2rep and FIV-34TF10-infected G355-5 cells,activity by incubating at 377 for 1 hr with [14C]-
chloramphenicol and acetyl-CoA, as described by Gor- as well as supernatant from FIV-PPR-infected PBLs, were
then used to infect MCH5-4 cells (CD4/ T lymphocytes)man et al. (1982). The acetylated and nonacetylated prod-
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cells and so minimal transactivation of the FIV wild-type
LTR could be seen in these cells. However, deleting por-
tions of U3 from the 5* end of the LTR reduced the basal
level of activity revealing transactivation of the 0113 LTR
construct by FIV-ORF2rep. No transactivation of the0113
LTR construct was seen with FIV-34TF10 (Fig. 4), indicat-
ing that the ORF2 gene product is responsible for this
transactivation. Cotransfections of CrFK cells with the
wild-type FIV LTR, internal control DNA (pRSV-b-Gal) and
plasmids containing the ORF2 gene driven by the CMV
promoter also show that ORF2 is capable of transactivat-
ing the FIV LTR (Fig. 5A). Although the basal level of
activity of the wild-type LTR is high in CrFK cells, the
CAT activity in cells cotransfected with the clone ex-
FIG. 2. Growth of FIV molecular clones transfected into G355-5 cells. pressing the PPR-ORF2 gene is 1.5- to 2-fold higher than
G355-5 cells were transfected with the FIV molecular clones: FIV-PPR, that in cells cotransfected with either the pRC/CMV vec-
FIV-34TF10, and FIV-ORF2rep. The course of infection was followed by tor alone (control) or with the clone expressing the trun-
RT assay. By 3 weeks postinfection both FIV-34TF10 and FIV-ORF2rep
cated ORF2 gene from FIV-34TF10 (Fig. 5A).had high levels of RT activity whereas the FIV-PPR did not.
The FIV LTR was also introduced by transfection into
HeLa cells, where the basal level of activity is lower (Fig.
5B). Cotransfections of HeLa cells with the wild-type FIVand PBLs and the course of infection followed by RT
LTR, internal control DNA (pRSV-b-Gal), and plasmidsactivity in the culture supernatant. The FIV-ORF2rep and
expressing the ORF2 gene show an average of three- toFIV-PPR supernatants both established a productive in-
fivefold increase in transactivation of the wild-type FIVfection in PBLs and MCH5-4 cells, whereas FIV-34TF10
LTR by the PPR-ORF2-expressing clone compared to theand mock-infected cells had no detectable RT, even at
vector alone (Fig. 5B). This level of transactivation is com-5 weeks postinfection (Figs. 3A and 3B). It is also interest-
parable to that shown for visna tat (Davis and Clements,ing to note that FIV-ORF2rep actually grows more effi-
1989).ciently in MCH5-4 cells than FIV-PPR (Fig. 3B), but FIV-
PPR has better growth kinetics in PBLs than FIV-ORF2rep
(Fig. 3A). DISCUSSION
Parallel infections of G355-5 and CrFK cells were also
This study explored the effect of the FIV ORF2 geneperformed with FIV-ORF2rep and FIV-34TF10 to see if
product on the ability of FIV to productively infect PBLs.FIV-ORF2rep has similar growth kinetics to the wild-type
Several FIV strains have been purified from PBLs andFIV-34TF10 in these cells. By 3 weeks postinfection, both
adapted to grow in CrFK and G355-5 cells, but this hasviruses had productively infected the cells, as indicated
not necessarily resulted in the loss of ability to grow inby the RT values of over 100,000 cpm/ml (Figs. 3C and
PBLs as appears to be the case with the molecular clone,3D). In both these cells the FIV-ORF2rep has improved
FIV-34TF10. Two infectious molecular clones of FIV, FIV-growth kinetics compared to FIV-34TF10.
34TF10 and FIV-PPR, have been shown to differ in theirFinally, virus containing supernatants from FIV-PPR-,
ability to productively infect PBLs, CrFK, and G355-5 cellsFIV-34TF10-, and FIV-ORF2rep-infected cells were used
(Phillips et al., 1990). FIV-34TF10 was cloned from theto infect unstimulated macrophages and PBLs. An RT
Petaluma isolate of FIV, as was another clone, pFIV-14assay was performed 10 days postinfection to detect
(Olmsted et al., 1989a). FIV-PPR and pFIV-14 are bothproductive infection (Table 1). FIV-PPR and FIV-ORF2rep
able to productively infect PBLs, and FIV-14 can produc-both caused a productive infection in PBLs and macro-
tively infect CrFK cells as well as PBLs, whereas FIV-phages, whereas FIV-34TF10 supernatant from both cell
34TF10 is not able to productively infect PBLs. Thetypes had a minimal RT value compared to FIV-PPR and
growth properties of FIV-ORF2rep more closely reflectFIV-ORF2rep.
those of FIV-14 than FIV-34TF10 as repair of ORF2 en-
ables FIV-34TF10 to grow in PBLs and macrophages.Transactivation assays
The ability of FIV-34TF10 to grow on CrFK and G355-5
cells, as well as the failure of FIV-PPR to grow on theseCrFK cells were infected with either FIV-34TF10 or FIV-
ORF2rep and then cotransfected with the various LTR cells is dictated by Env and is independent of the ORF2-
directed effects shown here (our unpublished observa-constructs (Thompson et al., 1994) and an internal control
DNA (pRSV-b-Gal). Extracts were normalized for protein tion). However, it should be noted that the growth rate
of FIV-34TF10 in CrFK and G355-5 cells is acceleratedcontent, following a b-Gal assay, and 4 units of each
extract was used for the CAT assays (Fig. 4). The FIV by repair of ORF2 (Figs. 3C and 3D). The findings here
are consistent with the findings of Tomonaga et al.LTR has a very high basal level of expression in CrFK
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FIG. 3. FIV-infected cell supernatants were used to infect (A) PBLs, (B) MCH5-4, (C) G355-5 and (D) CrFK cells. Virus growth in the cells was
followed by reverse transcriptase activity. FIV-ORF2rep, but not FIV-34TF10, can productively infect PBLs and a feline T cell line, MCH5-4. Also FIV-
ORF2rep has improved growth kinetics in both G355-5 and CrFK cells over FIV-34TF10. FIV-34TF10, h; FIV-ORF2rep, l; FIV-PPR, s; mock, n.
(1993a), who show that ORF2 mutants of FIV have a proteins of other retroviruses, in particular to visna virus
(Carruth et al., 1994) and caprine arthritis and encephali-severe defect in productive infection of PBLs, but they
are still able to replicate in CrFK cells. tis virus (Kalinski et al., 1994). Thompson et al. (1994)
prepared a series of LTR deletion constructs upstreamThe results are consistent with the interpretation that
ORF2 encodes a viral transactivator. The protein en- from the CAT reporter gene. They then assessed the
coded by ORF2 shares some homology to transactivating
TABLE 2
TABLE 1 FIV Cell Tropism
Growth of FIV Variants in Macrophages and PBLs
PPR 34TF10 Orf2rep
RT activity 1 week p.i.
PBL / 0 /
MCH 5-4 / 0 /Macrophages PBLs
MACROPHAGES / 0 /
CrFK 0 / /Mock 364 492
G355-5 0 / /Orf2rep 53,748 151,424
PPR 202,120 292,460
Note. /, FIV infection detected by reverse transcriptase assay; 0,34TF10 2,836 19,120
no detectable reverse transcriptase activity.
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removal of one AP4 site and the AP1 site greatly reduces
the basal level of CAT activity, but a 4.5-fold increase in
transactivation of the FIV LTR (0113) by ORF2 can still
be seen. However, truncation at 068, which removes the
second AP4 site, both C/EBP sites, and the NF1 and ATF
sites results in an LTR which has a very low basal level
of activity and is not susceptible to transactivation by
ORF2 (Fig. 4). Visna virus tat has not been shown to bind
directly to the visna virus LTR or RNA transcripts and so
it is thought to act through binding to cellular factors.
(Gdovin and Clements, 1992). Hydrophobic and bulky ar-
omatic domains have been shown to be important in
transactivation by other transactivators, including visna
virus tat (Cress and Triezenberg, 1991; Carruth et al.,
FIG. 4. Relative activity of FIV LTR deletion mutants. CrFK cells were 1994). These hydrophobic domains can be seen in the
infected with either FIV-34TF10 or FIV-ORF2rep or were mock infected
amino terminal of FIV-ORF2 and studies are underwayand then cotransfected with the various LTR–CAT constructs. Relative
in our laboratory to determine the domains important forCAT activity was determined as the percentage of chloramphenicol
converted to acetylated products. Removal of a potential down-regula- transactivation by FIV-ORF2, either directly or via cellular
tor element in the 0147 clone resulted in increased activity of the FIV factors.
LTR when compared to the 0176 clone. However, this activity is re- The cellular specificity of the ORF2-directed enhanced
duced significantly on removal of the AP-1/AP-4 motif, but is restored
virus expression implies a cell-specific interaction be-partially on infection with FIV-ORF2rep but not with FIV-34TF10.
tween the ORF2 gene product and a cellular factor. Many
cellular factors have been shown to be involved in retrovi-
ral regulation (reviewed by Tong-Starksen and Peterlin,influence of viral infection on CAT activity as a function
1990). Also, Miyazawa et al. (1993) have shown that theof U3 sequences. Although there was no detectable in-
FIV LTR can be activated by c-Fos, but not c-Jun in fcwf-crease of full-length LTR activity in FIV-UK8-infected
4 and CrFK cells. Although c-Fos and c-Jun may be im-cells, activity of a deletion mutant LTR lacking the AP-1/
portant in basal activity of the FIV LTR, they are probablyAP-4 site was restored on cotransfection with FIV-PPR
not involved in transactivation of the LTR by ORF2 sinceor FIV-UK8 but not 34TF10. This again suggests that FIV-
deletion of AP1 and AP4 sites, the most likely candidates34TF10 is lacking some sort of transactivator which may
for transactivation by c-Fos and c-Jun, does not preventact through cellular proteins on the FIV LTR on a region
transactivation by ORF2.distinct from the AP-1/AP-4 site. The data also indicate
that AP-1/AP-4 sites are important for basal LTR activity.
The LTRs of FIV-34TF10 and FIV-PPR are greater than
93% homologous and both have been shown to have a
strong basal promoter activity in most cell lines, including
CrFK, G355-5 cells, and PBLs (Sparger et al., 1992;
Thompson et al., 1994). This is similar to results seen
with visna virus LTR (Hess et al., 1985). Thus, the tissue
restriction of replication of FIV does not correlate with
the ability of the LTR to function as a promoter in various
cell types. Transactivation of the FIV LTR appears to be
very low, another similarity to the LTR of visna virus (Hess
et al., 1985; Davis and Clements, 1989; Gourdou et al.,
1989). Sparger et al. (1992) reported only a three- to five-
fold activation of the FIV LTR on cotransfection with FIV
provirus (FIV-PPR or FIV-34TF10), and they were unable
to detect transactivation from FIV-PPR ORF2 constitu-
tively expressed under the control of the SV40 promoter.
However, in the present study, CAT assays performed in
both CrFK cells, and a nonpermissive cell line (HeLa)
FIG. 5. CrFK (A) and HeLa (B) cells were cotransfected with 1 andwhere the basal level of activity is reduced, show that
10 mg, respectively, of the wild-type FIV LTR, 5 mg internal control DNAORF2 expressed under the control of the CMV promoter
(b-Gal), and 10 mg of the pRC/CMV vector (control), the FIV-34TF10is able to transactivate the FIV LTR, whereas the trun-
ORF2-expressing clone (34TF10 ORF2), or the FIV-PPR ORF2-express-
cated ORF2 from FIV-34TF10 causes no transactivation. ing clone (PPR-ORF2). In both cell types it can be seen that there is
What cis-acting element the transactivator targets is an increased CAT activity in cells cotransfected with the PPR-ORF2-
expressing clone.yet to be defined. The data presented here indicate that
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Lerner, D. L., Wagaman, P. C., Phillips, T. R., Prospero-Garcia, O., Hen-FIV-34TF10 replicated very poorly after inoculation into
riksen, S. J., Fox, H. S., Bloom, F. E., and Elder, J. H. (1995). Increasedcats, whereas FIV-PPR produces seroconversion in 6– 8
mutation frequency of FIV lacking functional deoxyuridine triphospha-
weeks postinfection (Sparger et al., 1994; Lerner et al., tase. Proc. Natl. Acad. Sci. USA 92, 7480–7484.
1995). This suggests that ORF2 could play an important Miyazawa, T., Kohmoto, M., Kawaguchi, Y., Tomonaga, K., Toyosaki, T.,
Ikuta, K., Adachi, A., and Mikami, T. (1993). The AP-1 binding site inrole in the in vivo life cycle of the virus. Repair of ORF2
the feline immunodeficiency virus long terminal repeat is not requiredenables FIV-34TF10 to grow in T lymphocytes which are
for virus replication in feline T lymphocytes. J. Gen. Virol. 74, 1573–primary targets cells of FIV in vivo. Experiments are un-
1580.
derway to assess the growth properties of FIV-ORF2rep Neuveut, C., Vigne, R., Clements, J. E., and Sire, J. (1993). The visna
in vivo. transcriptional activator tat: Effects on the viral LTR and on cellular
genes. Virology 197, 236–344.
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